Blue water biotech collaborates with iqvia to build medical sales representative team to market commercial product portfolio

Cincinnati, june 21, 2023 (globe newswire) -- blue water biotech, inc. (“blue water” or the “company”) (nasdaq: bwv), a biotechnology and pharmaceutical company spanning multiple sectors, today announced plans to establish a medical sales representative team with iqvia to market blue water's commercial portfolio. this portfolio is highlighted by entadfi®, a treatment for benign prostatic hyperplasia, and zontivity®, a medication for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction or with peripheral arterial disease.
BWV Ratings Summary
BWV Quant Ranking